Efficient Immune Cell Genome Engineering with Enhanced CRISPR Editing Tools.

Chan, Waipan; Gottschalk, Rachel A; Yao, Yikun; Pomerantz, Joel L; Germain, Ronald N

Chan, Waipan; Gottschalk, Rachel A; Yao, Yikun; Pomerantz, Joel L; Germain, Ronald N.

Afiliação

Chan W; Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; waipan.chan@nih.gov rgermain@niaid.nih.gov.
Gottschalk RA; Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Yao Y; Molecular Development of the Immune System Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and.
Pomerantz JL; Department of Biological Chemistry and Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Germain RN; Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; waipan.chan@nih.gov rgermain@niaid.nih.gov.

Immunohorizons ; 5(2): 117-132, 2021 02 23.

Article em En | MEDLINE | ID: mdl-33622708

Assuntos

Sistemas CRISPR-Cas/genética; Edição de Genes/métodos; Marcação de Genes/métodos; Sistema Imunitário; Animais; Humanos; Linfócitos/metabolismo; Macrófagos/metabolismo; Camundongos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Marcação de Genes / Sistemas CRISPR-Cas / Edição de Genes / Sistema Imunitário Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google